Literature DB >> 27633317

A mixed methods study of the administration of flucloxacillin oral liquid; identifying strategies to overcome administration issues of medicines with poor palatability.

Claudia Rouse1, Punam Mistry1, Oli Rayner2, Jess Nickless3, Mandy Wan4, Kevin W Southern5, Hannah K Batchelor1.   

Abstract

BACKGROUND: The palatability of flucloxacillin oral liquid is poor. Parents/carers use strategies to aid the administration of poorly palatable medicines. AIM: To assess views on the palatability of flucloxacillin oral liquid and identify factors associated with successful administration.
METHODS: A mixed methods study which included a structured review of online forums and a survey of parent/carers of children with cystic fibrosis (CF) to obtain parent/carer views on the administration of flucloxacillin oral liquid.
RESULTS: A total of 18 strategies to aid the administration of flucloxacillin suspension to children were identified on 10 different public online forums. A total of 255 responses to the open online survey were received with 47% of respondents reporting that administration of flucloxacillin was more problematic compared to other medicines and 38% reporting the need to improve the palatability. The brand of flucloxacillin oral liquid significantly influenced the degree of difficulty associated with administration to children. A significant relationship was found between the concentration of flucloxacillin and the reported number of doses successfully administered. The use of food and drink to aid administration was more commonly stated in online forums (44%) compared to the survey data of parents/carers of children with CF (15.9%).
CONCLUSION: The administration of flucloxacillin oral liquid is perceived as a challenge by parent/carers because of palatability. For chronic use, a more concentrated oral liquid and certain brands are likely to improve acceptability.
© 2016 Royal Pharmaceutical Society.

Entities:  

Keywords:  cystic fibrosis; flucloxacillin; paediatric; palatability

Mesh:

Substances:

Year:  2016        PMID: 27633317     DOI: 10.1111/ijpp.12308

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  7 in total

1.  Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children.

Authors:  Dillon T Wademan; Graeme Hoddinott; Susan E Purchase; James A Seddon; Anneke C Hesseling; Anthony J Garcia-Prats; Ria Reis; Lindsey J Reynolds
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

2.  Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.

Authors:  Margaret Rosenfeld; Oli Rayner; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2020-09-30

3.  Strategies parents use to give children oral medicine: a qualitative study of online discussion forums.

Authors:  Elin Høien Bergene; Torstein Baade Rø; Aslak Steinsbekk
Journal:  Scand J Prim Health Care       Date:  2017-06-05       Impact factor: 2.581

4.  Requests for new oral antibiotic prescriptions in children within 2 days: a Norwegian population-based study.

Authors:  E H Bergene; H Nordeng; T B Rø; A Steinsbekk
Journal:  Fam Pract       Date:  2018-12-12       Impact factor: 2.267

5.  In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances.

Authors:  Sharon J Gardiner; Philip G Drennan; Ronald Begg; Mei Zhang; Jared K Green; Heather L Isenman; Richard J Everts; Stephen T Chambers; Evan J Begg
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

6.  Practical Issues in Early Switching from Intravenous to Oral Antibiotic Therapy in Children with Uncomplicated Acute Hematogenous Osteomyelitis: Results from an Italian Survey.

Authors:  Elena Chiappini; Elena Serrano; Luisa Galli; Alberto Villani; Andrzej Krzysztofiak
Journal:  Int J Environ Res Public Health       Date:  2019-09-23       Impact factor: 3.390

Review 7.  It's not all about inhaled treatment: challenges with oral therapy in paediatric respiratory medicine.

Authors:  Anneka Sareen; Manisha Ramphul; Jayesh Mahendra Bhatt
Journal:  Breathe (Sheff)       Date:  2021-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.